TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07676097: Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study

Sponsor: AngioInsight · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 620 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07676097 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07676097 Rescue Dossier →